4I4G
Crystal structure of CYP3A4 ligated to oxazole-substituted desoxyritonavir
Summary for 4I4G
Entry DOI | 10.2210/pdb4i4g/pdb |
Related | 3NXU |
Descriptor | Cytochrome P450 3A4, PROTOPORPHYRIN IX CONTAINING FE, N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-N-[(2R,5R)-5-{[(1,3-oxazol-5-ylmethoxy)carbonyl]amino}-1,6-diphenylhexan-2-yl]-L-valinamide, ... (4 entities in total) |
Functional Keywords | monooxygenase, cytochrome p450 reductase, cytochrome b5, endoplasmic reticulum, cytochrome p450, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Endoplasmic reticulum membrane; Single-pass membrane protein: P08684 |
Total number of polymer chains | 1 |
Total formula weight | 57063.18 |
Authors | Sevrioukova, I.F.,Poulos, T.L. (deposition date: 2012-11-27, release date: 2013-04-24, Last modification date: 2023-09-20) |
Primary citation | Sevrioukova, I.F.,Poulos, T.L. Pyridine-Substituted Desoxyritonavir Is a More Potent Inhibitor of Cytochrome P450 3A4 than Ritonavir. J.Med.Chem., 56:3733-3741, 2013 Cited by PubMed: 23586711DOI: 10.1021/jm400288z PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.718 Å) |
Structure validation
Download full validation report